Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04501276
Title A Phase 1b Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Adagene Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS


No variant requirements are available.